Gila Therapeutics, Inc. — Form D/A
Gila Therapeutics, Inc. of Edina, MN, a company, filed a Form D amendment with the SEC on 2017-04-18. The offering totals $4.0M, of which $3.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-04-18
- Form: D/A
- Accession: 0001209191-17-027327
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $3.3M
- Remaining: $655K
- Investors: 33
- Date of first sale: 2016-04-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-262438
Issuer
- Name: Gila Therapeutics, Inc.
- CIK: 0001673503
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 5420 Highwood Drive West, Edina, MN, 55436
- Phone: 612-805-9054
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Christopher J DeSouza | Director | Minneapolis, MN |
| Andres J Acosta | Promoter | Minneapolis, MN |
| Sergei J Zolutukhin | Promoter | Minneapolis, MN |
| Praveen Tyle | Director | Encinitas, CA |
| Jon Freeman | Executive Officer | Santa Clara, CA |
| Timothy Barberich | Director | Edina, MN |
| Christopher De Souza | Director | Charlotte, NC |
| Thomas Vasicek | Executive Officer | Edina, MN |
| Richard Horan | Director | Edina, MN |
| Scott Schorer | Director | Edina, MN |
| Scott Schorer | Executive Officer | Edina, MN |
| Sangeeta Kashyap | Executive Officer | Edina, MN |
| Tom Vasicek | Executive Officer | Minneapolis, MN |
| Richard J Horan | Director | Minneapolis, MN |
| Thomas J Vasicek | Director | Minneapolis, MN |
| Thomas J Vasicek | Executive Officer | Minneapolis, MN |
| Thomas J Vasicek | Promoter | Minneapolis, MN |
| Christopher J de Souza | Director | Minneapolis, MN |
| Jon J Freeman | Executive Officer | Minneapolis, MN |
| Richard R Horan | Director | Minneapolis, MN |
| Jon R Freeman | Executive Officer | Minneapolis, MN |
| Christopher R DeSouza | Director | Minneapolis, MN |
| Michael R Cardenas | Promoter | Minneapolis, MN |
Other filings by this issuer (7)
More